Shree Hari Chemicals Preferential Warrant Issue ₹40.24 Cr

Board Meeting Date: August 25, 2026 (commenced at 12:15 PM, concluded at 6:00 PM)
Approval Authority: Board of Directors
Regulatory Reference: SEBI Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026

Type of Securities: Convertible Warrants convertible into an equal number of Equity Shares
Type of Issuance: Preferential allotment in accordance with Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 (ICDR Regulations)
Total Issue Size: 22,85,000 (Twenty Two Lakhs Eighty Five Thousand) Convertible Warrants
Issue Price: ₹176.10 per warrant at par
Total Aggregate Value: ₹40,23,88,500 (₹40.24 crore)
Face Value of Underlying Shares: ₹10 per equity share
Premium on Conversion: ₹166.10 per share

The warrants are being issued to four promoter individuals:

1. Shri Nihit Agarwal: 6,85,500 warrants

2. Smt. Priyamvada Agarwal: 6,85,500 warrants

3. Smt. Avanticka Agarwal: 4,57,000 warrants

4. Smt. Smradhi Agarwal: 4,57,000 warrants

Conversion Period: Convertible into equity shares in one or more tranches within eighteen months from the date of allotment
Payment Structure: Minimum 25% of the issue price payable at the time of subscription and allotment, with the balance 75% payable on or before the exercise of conversion rights within the 18-month period

Post-conversion of all warrants into equity shares, the expected shareholding pattern will be:

Shri Nihit Agarwal: Current holding 3,000 shares (0.05%) → Post-conversion 6,88,500 shares (8.01%)
Smt. Priyamvada Agarwal: Current holding 13,784 shares (0.22%) → Post-conversion 6,99,284 shares (8.13%)
Smt. Avanticka Agarwal: Current holding 4,107 shares (0.07%) → Post-conversion 4,61,107 shares (5.36%)
Smt. Smradhi Agarwal: Current holding 37,000 shares (0.59%) → Post-conversion 4,94,000 shares (5.75%)

Number of Investors/Allottees: 4
Price Determination: Issue price of ₹176.10 per warrant determined in accordance with ICDR Regulations
Cancellation/Termination: Not applicable as per the disclosure
Next Steps: Subject to approval of shareholders of the Company